Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BS

Beate Schmidt — 21 Patents

NGNycomed Gmbh: 8 patents #4 of 92Top 5%
AAAltana Pharma Ag: 7 patents #6 of 76Top 8%
TGTakeda Gmbh: 6 patents #3 of 121Top 3%
Allensbach, DE: #2 of 39 inventorsTop 6%
Overall (All Time): #201,324 of 4,157,543Top 5%
21 Patents All Time
Beate Schmidt has been granted 21 US patents while listed as an inventor at Nycomed Gmbh. The first was granted in 2003 and the most recent in August 2016. Beate Schmidt ranks #201,324 of 4,157,543 US inventors in our database (top 4.8%). Patent records list Beate Schmidt in Allensbach, DE.

Patents per Year

Patents granted per year, 2003 to 2016Bar chart with a peak of 3 patents in 2008.peak 32003: 1 patents20032004: 1 patents2005: 2 patents20052006: 1 patents2007: 1 patents20072008: 3 patents2009: 3 patents20092011: 1 patents2012: 2 patents20122013: 2 patents2014: 1 patents20142015: 1 patents2016: 2 patents2016

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9422327 Process for preparing crystalline ciclesonide with defined particle size 2016-08-23
9340522 Pyrazolone-derivatives and their use as PDE-4 inhibitors Imre Schlemminger, Dieter Flockerzi, Hermann Tenor, Christof Zitt, Armin Hatzelmann +6 more 2016-05-17
9090597 Pyrazolone derivatives as PDE4 inhibitors Christian Scheufler, Jürgen Volz, Martin Feth, Rolf-Peter Hummel, Armin Hatzelmann +9 more 2015-07-28
8865745 Pyrazolone derivatives as PDE4 inhibitors Christian Scheufler, Juergen Volz, Martin Feth, Rolf-Peter Hummel, Armin Hatzelmann +9 more 2014-10-21
8609848 Pyrazolone-derivatives and their use as PDE-4 inhibitors Imre Schlemminger, Dieter Flockerzi, Hermann Tenor, Christof Zitt, Armin Hatzelmann +6 more 2013-12-17
8541456 Roflumilast for the treatment of diabetes mellitus type 2 Hans-Peter Kley, Guido Hanauer, Daniela Hauser, Dirk Bredenbröker, Wilhelm Wurst +1 more 2013-09-24
8304436 Pyrazolone derivatives as PDE4 inhibitors Christian Scheufler, Juergen Volz, Martin Feth, Rolf-Peter Hummel, Armin Hatzelmann +9 more 2012-11-06
8202880 3-hydroxy-6-phenylphenanthridines as PDE4 inhibitors Ulrich Kautz 2012-06-19
8017633 Roflumilast for the treatment of diabetes mellitus Hans-Peter Kley, Guido Hanauer, Daniela Hauser, Dirk Bredenbroeker, Wilhelm Wurst +1 more 2011-09-13
7632844 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors Ulrich Kautz 2009-12-15
7531540 Phthalazinone-piperidino-derivatives as PDE4 inhibitors Gerhard Grundler, Geert Jan Sterk 2009-05-12
7524973 Nitrate esters of phenylaminothiophenacetic acid derivatives 2009-04-28
7468433 Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation 2008-12-23
7423046 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors Ulrich Kautz 2008-09-09
7329676 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors Ulrich Kautz 2008-02-12
7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors Gerhard Grundler, Geert Jan Sterk 2007-02-20 $178,000
7022696 Piperazino-derivatives and their use as PDE4 inhibitor Gerhard Grundler, Geert Jan Sterk 2006-04-04 $138,000
6953853 Phthalazinone-piperidino-derivatives as PDE4 inhibitors Gerhard Grundler, Geert Jan Sterk 2005-10-11 $573,000
6884802 6-heteroarylphenanthridines 2005-04-26 $608,000
6818651 (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors Steffen Weinbrenner, Gerhard Grundler, Josef Stadlwieser, Armin Hatzelmann, Geert Jan Sterk 2004-11-16 $332,000
6630483 Phenanthridine-N-oxides 2003-10-07 $816,000